hydroxychloroquine and quinacrine

hydroxychloroquine has been researched along with quinacrine in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	29 (46.77)	18.7374
1990's	6 (9.68)	18.2507
2000's	9 (14.52)	29.6817
2010's	14 (22.58)	24.3611
2020's	4 (6.45)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL	1
He, E; Xiao, R; Zeng, R; Zhang, A; Zhao, J	1
Lanciani, P	1
Bell, AL; Betts, WH; Cleland, LG; French, JK; Hurst, NP; Nuki, G; O'Donnell, ML	1
Franks, A; Werth, V	1
Clark, SK	1
Boström, H; Whitehouse, MW	1
Cowey, FK; Whitehouse, MW	1
Brown, RK	1
Ball, EG; Markus, HB	1
Dodge, BG; Freeman, RG; Knox, JM	1
Carr, RE; Henkind, P; Rothfield, N; Siegel, IM	1
Elslager, EF; Tendick, FH; Werbel, LM	1
Koranda, FC	1
Hughes, GR; Lanham, JG	1
Elgart, M; Isaacson, D; Turner, ML	1
Tanenbaum, L; Tuffanelli, DL	1
Olansky, AJ	1
Cox, NH; Paterson, WD	1
Feldmann, R; Salomon, D; Saurat, JH	1
Wallace, DJ	1
Mehregan, DR; Su, WP	1
Rynes, RI	1
Chung, HS; Hann, SK	1
Golan, TD; Kessel, A; Rosner, I; Rozenbaum, M; Toubi, E	1
Cohen, JB	1
Golan, TD; Kessel, A; Lorber, M; Paran, D; Rosner, I; Rozenbaum, M; Sabo, E; Toubi, E	1
ANSELL, HB; APPEL, B; SCHIFF, B; TYE, MJ; WOLF, M	1
ANSELL, HB; APPEL, B; TYE, MJ; WHITE, H	1
FREDRIKSSON, T; LODIN, A; ROSENGREN, S	1
ABRAHAM, RK; DUBOIS, EI; TUFFANELLI, D	1
CAHN, MM; LEVY, EJ; SHAFFER, B	1
ARORA, RB; LAL, A	1
BORC, K	1
BOUMA, HG; DEVRIES, K; JANSZ, A; NIEWEG, HO	1
SULLI, G; VARRONE, F	1
BOTTIROLI, JA; ROSENBERG, FJ	1
ALVING, AS; BREWER, GJ; MILLAR, JW; POWELL, RD	1
RUTLEDGE, WU	1
BETTLEY, FR	1
Geraminejad, P; Sontheimer, RD; Stone, MS	1
Tutor-Ureta, P; Yebra-Bango, M	1
Iczkowski, KA; Kelly, BJ; Mrstik, ME; Ramos-Caro, FA	1
Kessel, A; Paran, D; Rosner, I; Rozenbaum, M; Shoenfeld, Y; Toubi, E	1
Bazzani, C; Calzavara-Pinton, PG; Cattaneo, R; Cavazzana, I; Ceribelli, A; Franceschini, F; Sala, R; Tincani, A; Zane, C	1
Bayliss, SJ; Berk, DR; Lu, D; Miller, A; Scarlett, D; Wippold, FJ	1
Chang, AY; Foering, KP; Okawa, J; Piette, EW; Tenhave, TR; Werth, VP	1
Chang, AY; Feng, R; Foering, KP; Okawa, J; Piette, EW; Ten Have, TR; Werth, VP	1
Callen, JP	1
Gonzalez-Rivera, T; McCune, WJ	1
Bakardzhiev, I; Chokoeva, AA; Krasnaliev, I; Lotti, T; Tana, C; Tchernev, G; Wollina, U	1
Kahlenberg, JM; Stannard, JN	1
Marceau, F; Parks, A	1
Alves, P; Bashir, MM; Feng, R; Werth, VP; Wysocka, M; Zeidi, M	1
Agesta, N; Martinez-Zapico, A; Ortego-Centeno, N; Porta, S; Ríos, R; Ruiz-Irastorza, G; Ugarte, A	1
Danza, A; Ruiz-Irastorza, G; Ugarte, A	1
Chansky, PB; Werth, VP; Zeidi, M	1
Kim, HJ; Werth, VP; Zeidi, M	1
Birring, S; Brex, P; Galloway, J; Larkin, G; Murgatroyd, F; Paolino, A; Patel, A; Sado, D; Walsh, S	1
Chakka, S; Chen, KL; Desai, K; Kim, HJ; Lim, R; Patel, J; Werth, VP; Zeidi, M	1
Chin, F; Dan, J; Diaz, D; Feng, R; Grinnell, M; Keyes, E; Li, Y; Patel, J; Sharma, M; Sprow, G; Vazquez, T; Werth, VP; Yan, D	1

Reviews

12 review(s) available for hydroxychloroquine and quinacrine

Article	Year
Recent update on anti-dengue drug discovery. European journal of medicinal chemistry, 2019, Aug-15, Volume: 176 Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication	2019
Small molecules targeting cGAS-STING pathway for autoimmune disease. European journal of medicinal chemistry, 2022, Aug-05, Volume: 238 Topics: Autoimmune Diseases; Humans; Inflammation; Membrane Proteins; Nucleotidyltransferases; Signal Transduction	2022
Antimalarials. Journal of the American Academy of Dermatology, 1981, Volume: 4, Issue:6 Topics: Antimalarials; Chloroquine; DNA; Eye Diseases; Humans; Hydroxychloroquine; Quinacrine; RNA; Skin Diseases	1981
Antimalarial therapy in SLE. Clinics in rheumatic diseases, 1982, Volume: 8, Issue:1 Topics: Antimalarials; Binding Sites; Chloroquine; Corneal Diseases; Dose-Response Relationship, Drug; Female; Humans; Hydroxychloroquine; Immune Tolerance; Inflammation; Kinetics; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Nucleoproteins; Photosensitivity Disorders; Pregnancy; Quinacrine; Retinal Diseases; Retinal Pigments; Skin Diseases; Virus Replication	1982
Anti-malarials in dermatology. International journal of dermatology, 1982, Volume: 21, Issue:7 Topics: Absorption; Amodiaquine; Antimalarials; Chemical Phenomena; Chemistry; Chloroquine; Female; Humans; Hydroxychloroquine; Quinacrine; Skin Diseases	1982
Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine. Archives of dermatology, 1980, Volume: 116, Issue:5 Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Chloroquine; DNA; Eye Diseases; Female; Hematologic Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Melanins; Neuromuscular Diseases; Porphyrias; Pregnancy; Quinacrine; Skin; Sunscreening Agents	1980
Antimalarials and ophthalmologic safety. Journal of the American Academy of Dermatology, 1982, Volume: 6, Issue:1 Topics: Antimalarials; Arthritis, Rheumatoid; Chloroquine; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Quinacrine; Retinal Diseases	1982
Antimalarial agents and lupus. Rheumatic diseases clinics of North America, 1994, Volume: 20, Issue:1 Topics: Antibodies, Antiphospholipid; Antimalarials; Chloroquine; Female; Humans; Hydroxychloroquine; Kidney Diseases; Lupus Erythematosus, Systemic; Neuromuscular Diseases; Pregnancy; Quinacrine	1994
Antimalarial drugs in the treatment of rheumatological diseases. British journal of rheumatology, 1997, Volume: 36, Issue:7 Topics: Antimalarials; Chloroquine; Contraindications; Female; Humans; Hydroxychloroquine; Male; Pregnancy; Pregnancy Complications; Quinacrine; Rheumatic Diseases; Skin	1997
[EXTRAMALARIAL THERAPUETIC APPLICATIONS OF ANTIMALARIAL DRUGS. 1. CLINICAL UTILIZATIONS]. La Clinica terapeutica, 1963, Oct-31, Volume: 27 Topics: Amodiaquine; Antimalarials; Chloroquine; Collagen Diseases; Dermatology; Drug Utilization; Epilepsy; Female; Heart Diseases; Hematology; Humans; Hydroxychloroquine; Hypersensitivity; Multiple Sclerosis; Muscular Diseases; Neurology; Parasitic Diseases; Pharmacology; Primaquine; Proguanil; Pyrimethamine; Quinacrine; Quinine; Toxicology; Uterus	1963
Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus. Current opinion in rheumatology, 2016, Volume: 28, Issue:5 Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimalarials; Autoantibodies; CTLA-4 Antigen; Cytokines; Dapsone; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation; HLA Antigens; Humans; Hydroxychloroquine; Interferon Regulatory Factors; Interferon Type I; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Quinacrine; Sunscreening Agents; Tumor Necrosis Factor-alpha; TYK2 Kinase; Ultraviolet Rays	2016
Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions. Current opinion in rheumatology, 2018, Volume: 30, Issue:5 Topics: Antimalarials; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisone; Quinacrine; Treatment Outcome	2018

Trials

3 trial(s) available for hydroxychloroquine and quinacrine

Article	Year
The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients. Lupus, 2000, Volume: 9, Issue:2 Topics: Adult; Antimalarials; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Quinacrine; Time Factors	2000
Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLE. Lupus, 2003, Volume: 12, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Antimalarials; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisone; Quinacrine; Severity of Illness Index	2003
The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus. Scandinavian journal of immunology, 2006, Volume: 63, Issue:4 Topics: Adult; Antibodies, Anticardiolipin; Antirheumatic Agents; Azathioprine; B-Cell Activating Factor; Case-Control Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Membrane Proteins; Middle Aged; Prednisolone; Quinacrine; Severity of Illness Index; Tumor Necrosis Factor-alpha	2006

Other Studies

47 other study(ies) available for hydroxychloroquine and quinacrine

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
[Synthetic antimalarials in the therapy of rheumatoid arthritis: adverse effects and advantages]. Minerva medica, 1985, Oct-06, Volume: 76, Issue:38 Topics: Arthritis, Rheumatoid; Chloroquine; Drug Evaluation; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Hydroxychloroquine; Quinacrine; Time Factors	1985
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochemical pharmacology, 1986, Sep-15, Volume: 35, Issue:18 Topics: Arachidonic Acid; Arachidonic Acids; Calcimycin; Cell Survival; Chloroquine; Fluorides; Humans; Hydroxychloroquine; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Phospholipids; Quinacrine; Superoxides; Tetradecanoylphorbol Acetate; Zymosan	1986
Treatment of discoid skin lesions with azathioprine. Archives of dermatology, 1986, Volume: 122, Issue:7 Topics: Azathioprine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Quinacrine	1986
Cutaneous lupus erythematosus. Recognition of its many forms. Postgraduate medicine, 1986, Volume: 79, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Chloroquine; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Male; Quinacrine; Sex Factors; Skin; Skin Diseases	1986
Biochemical properties of anti-inflammatory drugs. VI. The effects of chloroquine (resochin), mepacrine (quinacrine) and some of their potential metabolites on cartilage metabolism and oxidative phosphorylation. Biochemical pharmacology, 1965, Volume: 14, Issue:8 Topics: Animals; Cartilage; Chloroquine; Glycosaminoglycans; Gold; Hydroxychloroquine; In Vitro Techniques; Indomethacin; Oxidative Phosphorylation; Polysaccharides; Quinacrine; Quinolines; Rats; Sulfates; Sulfur Isotopes; Thiosulfates	1965
Biochemical properties of anti-inflammatory drugs. VII. Inhibition of proteolytic enzymes in connective tissue by chloroquine (resochin) and related antimalarial antirheumatic drugs. Biochemical pharmacology, 1966, Volume: 15, Issue:8 Topics: Acridines; Animals; Cartilage; Cattle; Chloroquine; Chondroitin; Connective Tissue; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Hydroxychloroquine; Microbial Collagenase; Mucoproteins; Papain; Primaquine; Quaternary Ammonium Compounds; Quinacrine; Rabbits	1966
Discoid lupus erythematosus. Archives of dermatology, 1972, Volume: 105, Issue:5 Topics: Adult; Antimalarials; Chloroquine; Color Vision Defects; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Quinacrine; Retinal Diseases	1972
Inhibition of lipolytic processes in rat adipose tissue by antimalaria drugs. Biochimica et biophysica acta, 1969, Dec-17, Volume: 187, Issue:4 Topics: Adipose Tissue; Animals; Antimalarials; Chloroquine; Epididymis; Fatty Acids; Heparin; Hydroxychloroquine; Lipid Metabolism; Male; Primaquine; Quinacrine; Quinidine; Quinine; Rats	1969
Erythema dyschromicum perstans. Archives of dermatology, 1968, Volume: 97, Issue:3 Topics: Adolescent; Adult; Biopsy; Blood Cell Count; Blood Sedimentation; Child, Preschool; Chloroquine; Erythema; Feces; Female; Humans; Hydroquinones; Hydroxychloroquine; Male; Middle Aged; Parasitic Diseases; Prednisone; Quinacrine; Steroids; Syphilis Serodiagnosis; Triamcinolone	1968
Ocular toxicity of antimalarial drugs. Long-term follow-up. American journal of ophthalmology, 1968, Volume: 66, Issue:4 Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Electrooculography; Electroretinography; Eye Diseases; Follow-Up Studies; Fundus Oculi; Humans; Hydroxychloroquine; Light; Lupus Erythematosus, Systemic; Macula Lutea; Middle Aged; Ophthalmoscopy; Quinacrine; Retinitis; Vision Tests; Visual Fields	1968
Repository drugs. 8. Ester and amide congeners of amodiaquine, hydroxychloroquine, oxychloroquine, primaquine, quinacrine, and related substances as potential long-acting antimalarial agents. Journal of medicinal chemistry, 1969, Volume: 12, Issue:4 Topics: Amodiaquine; Animals; Antimalarials; Chemical Phenomena; Chemistry; Delayed-Action Preparations; Esters; Hydroxychloroquine; Malaria; Mice; Primaquine; Quinacrine	1969
Ocular toxicity of antimalarials in dermatology: a survey of current practice. The British journal of dermatology, 1994, Volume: 131, Issue:6 Topics: Antimalarials; Dermatology; Drug Administration Schedule; Humans; Hydroxychloroquine; Quinacrine; Referral and Consultation; Retinal Diseases; Risk Factors; Skin Diseases; Time Factors	1994
The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology (Basel, Switzerland), 1994, Volume: 189, Issue:4 Topics: Adult; Aged; Chloroquine; Drug Combinations; Drug Tolerance; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Male; Middle Aged; Quinacrine; Vision Disorders	1994
Cyclosporine treatment for dermatomyositis/polymyositis. Cutis, 1993, Volume: 51, Issue:1 Topics: Azathioprine; Cyclosporine; Dermatomyositis; Female; Humans; Hydroxychloroquine; Middle Aged; Polymyositis; Prednisone; Quinacrine	1993
Lupus panniculitis treated by a combination therapy of hydroxychloroquine and quinacrine. The Journal of dermatology, 1997, Volume: 24, Issue:9 Topics: Adult; Antimalarials; Antirheumatic Agents; Drug Therapy, Combination; Humans; Hydroxychloroquine; Male; Panniculitis, Lupus Erythematosus; Quinacrine	1997
Cutaneous involvement of dermatomyositis can respond to Dapsone therapy. International journal of dermatology, 2002, Volume: 41, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Dapsone; Dermatomyositis; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Prednisone; Quinacrine	2002
Treatment of chronic lupus erythematosus: effectiveness of plaquenil and APA (Aralen 65 mg., plaquenil 50 mg., Atabrine 25 mg.) as compared with Aralen, with observations on side-reactions and toxicity; report and presentation of unusual cases. A.M.A. archives of dermatology, 1958, Volume: 77, Issue:4 Topics: Antimalarials; Chloroquine; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Quinacrine	1958
Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine. The New England journal of medicine, 1959, Jan-08, Volume: 260, Issue:2 Topics: Chloroquine; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Quinacrine	1959
[Treatment of discoid lupus erythematosus, polymorphous photodermatosis and rosacea with Triquin--a combination of 3 anti-malarials]. Svenska lakartidningen, 1962, Oct-04, Volume: 59 Topics: Antimalarials; Chloroquine; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Photosensitivity Disorders; Quinacrine; Rosacea	1962
PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS. Archives of dermatology, 1963, Volume: 88 Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Cornea; Eye; Eye Manifestations; Histocytochemistry; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Photomicrography; Pigmentation; Pigmentation Disorders; Quinacrine; Retina; Toxicology	1963
POLYMORPHOUS LIGHT ERUPTION. A TEN-YEAR FOLLOW-UP AND EVALUATION. Archives of dermatology, 1963, Volume: 88 Topics: Chloroquine; Dermatitis, Phototoxic; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Photosensitivity Disorders; Prurigo; Quinacrine; Seasons; Sunlight	1963
ANTIMALARIAL DRUGS ON THE AUTOMATICITY OF SINO-AURICULAR AND ATRIO-VENTRICULAR NODES. The Indian journal of medical research, 1963, Volume: 51 Topics: Administration, Intravenous; Amodiaquine; Animals; Anti-Arrhythmia Agents; Antimalarials; Atrioventricular Node; Atropine; Chloroquine; Dogs; Heart Conduction System; Humans; Hydroxychloroquine; Hypotension; Injections, Intravenous; Primaquine; Quinacrine; Quinidine; Research; Statistics as Topic	1963
[CHRONIC DISCOID ERYTHEMATOSUS (REPORT ON 69 CASES OVER A PERIOD OF 6 YEARS FROM THE VIEWPOINT OF OPTIMUM THERAPY)]. Ceskoslovenska dermatologie, 1963, Volume: 38 Topics: Antimalarials; Chloroquine; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Quinacrine	1963
HAEMATOLOGICAL SIDE-EFFECTS OF SOME ANTI-RHEUMATIC DRUGS. Annals of the rheumatic diseases, 1963, Volume: 22 Topics: Aminopyrine; Antirheumatic Agents; Aspirin; Blood Platelets; Chloroquine; Colchicine; Complement Fixation Tests; Drug Hypersensitivity; Gold; Humans; Hydroxychloroquine; Meprobamate; Phenacetin; Phenylbutazone; Probenecid; Purpura; Purpura, Thrombocytopenic; Quinacrine; Rheumatic Diseases; Splenectomy; Toxicology	1963
ANTIMALARIALS AND OTHER ANTICONVULSANT DRUGS: PREDICTIVE VALIDITY OF LABORATORY TESTS. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1964, Volume: 115 Topics: Animals; Anticonvulsants; Antimalarials; Chloroquine; Electric Stimulation; Hydroxychloroquine; Mice; Pentylenetetrazole; Pharmacology; Phenobarbital; Phenytoin; Quinacrine; Research; Seizures	1964
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND. Bulletin of the World Health Organization, 1964, Volume: 30 Topics: Amodiaquine; Antimalarials; Asia, Southeastern; Biomedical Research; Chloroquine; Drug Resistance; Drug Resistance, Microbial; Humans; Hydroxychloroquine; Malaria; Malaria, Falciparum; Pharmacology; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinacrine; Quinine; Thailand	1964
WHAT'S NEW AND WHAT'S TRUE OF WHAT'S NEW IN DERMATOLOGY. The Journal of the Kentucky Medical Association, 1964, Volume: 62 Topics: Amodiaquine; Dermatology; Humans; Hydroxychloroquine; Keratoacanthoma; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Psoriasis; Quinacrine; Quinine; Steroids; Toxicology	1964
CHILBLAIN LUPUS ERYTHEMATOSUS. Proceedings of the Royal Society of Medicine, 1964, Volume: 57 Topics: Chilblains; Chloroquine; Fluocinolone Acetonide; Frostbite; Humans; Hydroxychloroquine; Hypothyroidism; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Niacinamide; Quinacrine; Telangiectasis; Triamcinolone	1964
Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus. Lupus, 2004, Volume: 13, Issue:6 Topics: Antimalarials; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Lichenoid Eruptions; Lupus Erythematosus, Cutaneous; Middle Aged; Quinacrine	2004
[Systemic lupus erythematosus therapy. Antimalarials in inflammatory diseases]. Revista clinica espanola, 2004, Volume: 204, Issue:11 Topics: Antimalarials; Chloroquine; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Quinacrine	2004
Papular elastolytic giant cell granuloma responding to hydroxychloroquine and quinacrine. International journal of dermatology, 2004, Volume: 43, Issue:12 Topics: Aged; Dermatologic Agents; Elastic Tissue; Exanthema; Giant Cells; Granuloma, Giant Cell; Humans; Hydroxychloroquine; Lymphocytes; Male; Quinacrine; Skin Diseases, Papulosquamous; Treatment Outcome	2004
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. Lupus, 2009, Volume: 18, Issue:8 Topics: Adult; Antimalarials; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Middle Aged; Quinacrine; Retrospective Studies; Skin; Treatment Outcome	2009
Osseous metaplasia late in the course of nephrogenic systemic fibrosis. Dermatology online journal, 2010, Aug-15, Volume: 16, Issue:8 Topics: Adult; Analgesics; Calcinosis; Disease Progression; Female; gamma-Aminobutyric Acid; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Kidney Transplantation; Lupus Erythematosus, Systemic; Metaplasia; Nephrogenic Fibrosing Dermopathy; Pregabalin; Quinacrine; Skin; Thalidomide; Treatment Outcome	2010
Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis. Archives of dermatology, 2011, Volume: 147, Issue:11 Topics: Adolescent; Adult; Aged; Antimalarials; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Longitudinal Studies; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Prospective Studies; Quinacrine; Severity of Illness Index; Treatment Outcome; Young Adult	2011
Impact of smoking in cutaneous lupus erythematosus. Archives of dermatology, 2012, Volume: 148, Issue:3 Topics: Adult; Antimalarials; Cohort Studies; Comorbidity; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunologic Factors; Longitudinal Studies; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Prospective Studies; Quality of Life; Quinacrine; Smoking; Young Adult	2012
Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus". Archives of dermatology, 2011, Volume: 147, Issue:11 Topics: Antimalarials; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male; Quinacrine	2011
Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity? Current opinion in rheumatology, 2015, Volume: 27, Issue:3 Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Diseases; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Quinacrine; Remission Induction; Time Factors	2015
Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem. Wiener medizinische Wochenschrift (1946), 2016, Volume: 166, Issue:7-8 Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Chloroquine; Combined Modality Therapy; Dapsone; Diagnosis, Differential; Humans; Hydroxychloroquine; Lasers, Dye; Lupus Erythematosus, Discoid; Male; Ointments; Quinacrine; Skin; Sunscreening Agents; Tacrolimus	2016
Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation. Toxicology and applied pharmacology, 2016, 08-15, Volume: 305 Topics: Amiodarone; Anticholesteremic Agents; Autophagy; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chloroquine; Cholesterol; Cytostatic Agents; Cytotoxins; Human Umbilical Vein Endothelial Cells; Humans; Hydroxychloroquine; Lidocaine; Lovastatin; Lysosomes; Microtubule-Associated Proteins; Poly (ADP-Ribose) Polymerase-1; Procainamide; Quinacrine	2016
Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus. The journal of investigative dermatology. Symposium proceedings, 2017, Volume: 18, Issue:2 Topics: Antimalarials; Cells, Cultured; Dendritic Cells; Dermatomyositis; Drug Interactions; Humans; Hydroxychloroquine; Interferon-alpha; Leukocytes, Mononuclear; Lipopolysaccharides; Lupus Erythematosus, Cutaneous; Monocytes; Quinacrine; Tumor Necrosis Factor-alpha	2017
Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity. Lupus, 2018, Volume: 27, Issue:10 Topics: Adult; Antimalarials; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Joint Diseases; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Male; Middle Aged; Quinacrine; Remission Induction; Retrospective Studies; Smokers; Treatment Outcome	2018
Acute onset/flares of dermatomyositis following ingestion of IsaLean herbal supplement: Clinical and immunostimulatory findings. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:3 Topics: Acute Disease; Autoantibodies; Autoimmune Diseases; Dermatomyositis; Dietary Supplements; Humans; Hydroxychloroquine; Interferon-alpha; Interferon-beta; Leukocytes, Mononuclear; Lipopolysaccharides; Primary Cell Culture; Quinacrine; Symptom Flare Up; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2019
Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus. The Journal of investigative dermatology, 2019, Volume: 139, Issue:2 Topics: Adult; Antimalarials; Dendritic Cells; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Quinacrine; Skin; Treatment Outcome; Tumor Necrosis Factor-alpha	2019
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service. Clinical and experimental dermatology, 2021, Volume: 46, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Clinical Protocols; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Interleukin-12; Interleukin-23; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Phenotype; Prospective Studies; Quinacrine; Referral and Consultation; Remission Induction; Sarcoidosis; Skin Diseases; Tertiary Care Centers; Tumor Necrosis Factor Inhibitors; Young Adult	2021
Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials. Lupus, 2022, Volume: 31, Issue:4 Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antimalarials; Female; Fluorescent Antibody Technique; Humans; Hydroxychloroquine; Immunohistochemistry; Lectins, C-Type; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Quinacrine; Receptors, CCR7; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; T-Lymphocytes; Treatment Outcome	2022
Multidimensional Immune Profiling of Cutaneous Lupus Erythematosus In Vivo Stratified by Patient Response to Antimalarials. Arthritis & rheumatology (Hoboken, N.J.), 2022, Volume: 74, Issue:10 Topics: Antimalarials; Granzymes; Humans; Hydroxychloroquine; Immunosuppressive Agents; Interferon Regulatory Factor-3; Interferons; Interleukin-17; Interleukin-4; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Quinacrine	2022